These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24470212)

  • 1. Novel endogenous glycan therapy for retinal diseases: safety, in vitro stability, ocular pharmacokinetic modeling, and biodistribution.
    Swaminathan S; Li H; Palamoor M; de Obarrio WT; Madhura D; Meibohm B; Jablonski MM
    AAPS J; 2014 Mar; 16(2):311-23. PubMed ID: 24470212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NA3 glycan: a potential therapy for retinal pigment epithelial deficiency.
    Chintalapudi SR; Wang X; Wang X; Shi Y; Kocak M; Palamoor M; Davis RN; Hollingsworth TJ; Jablonski MM
    FEBS J; 2019 Dec; 286(24):4876-4888. PubMed ID: 31322324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraocular Pharmacokinetics of Intravitreal Aflibercept (Eylea) in a Rabbit Model.
    Park SJ; Choi Y; Na YM; Hong HK; Park JY; Park KH; Chung JY; Woo SJ
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2612-7. PubMed ID: 27258433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye.
    Chastain JE; Sanders ME; Curtis MA; Chemuturi NV; Gadd ME; Kapin MA; Markwardt KL; Dahlin DC
    Exp Eye Res; 2016 Apr; 145():58-67. PubMed ID: 26474497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of Sirolimus in a Novel Liposome Delivery System in Selected Ocular Tissues and Plasma Following a Single Subconjunctival Injection in Dutch Belted Rabbits.
    Brooks D; Linares-Alba MA; Garcia-Santisteban R; Xie E; Gum G; Manza LL; Servitje-Azcarraga L; Santisteban DG; García-Sánchez GA
    J Ocul Pharmacol Ther; 2022; 38(6):424-432. PubMed ID: 35834571
    [No Abstract]   [Full Text] [Related]  

  • 6. Ocular pharmacokinetics of dorzolamide and brinzolamide after single and multiple topical dosing: implications for effects on ocular blood flow.
    Kadam RS; Jadhav G; Ogidigben M; Kompella UB
    Drug Metab Dispos; 2011 Sep; 39(9):1529-37. PubMed ID: 21673129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular biodistribution of bevasiranib following a single intravitreal injection to rabbit eyes.
    Dejneka NS; Wan S; Bond OS; Kornbrust DJ; Reich SJ
    Mol Vis; 2008 May; 14():997-1005. PubMed ID: 18523657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular distribution of difluprednate ophthalmic emulsion 0.05% in rabbits.
    Tajika T; Isowaki A; Sakaki H
    J Ocul Pharmacol Ther; 2011 Feb; 27(1):43-9. PubMed ID: 21118027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular Pharmacokinetics of Therapeutic Antibodies Given by Intravitreal Injection: Estimation of Retinal Permeabilities Using a 3-Compartment Semi-Mechanistic Model.
    Hutton-Smith LA; Gaffney EA; Byrne HM; Maini PK; Gadkar K; Mazer NA
    Mol Pharm; 2017 Aug; 14(8):2690-2696. PubMed ID: 28631484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and ocular tissue distribution of an antiglaucoma prostanoid, tafluprost, after ocular instillation to monkeys.
    Fukano Y; Kawazu K; Akaishi T; Bezwada P; Pellinen P
    J Ocul Pharmacol Ther; 2011 Jun; 27(3):251-9. PubMed ID: 21491995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability and pharmacokinetics of intravitreal sirolimus.
    Mudumba S; Bezwada P; Takanaga H; Hosoi K; Tsuboi T; Ueda K; Kawazu K; Ali Y; Naor J
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):507-14. PubMed ID: 22662868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular pharmacokinetics profile of different indomethacin topical formulations.
    Bucolo C; Melilli B; Piazza C; Zurria M; Drago F
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):571-6. PubMed ID: 22059858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of the ocular safety of excipient maleic acid following intravitreal injection in rabbits.
    Aguirre SA; Collette W; Gukasyan HJ; Huang W
    Toxicol Pathol; 2012 Jul; 40(5):797-806. PubMed ID: 22552388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular Biodistribution of Once-Daily 0.6% Bilastine Eye Drops Reveals Highest Levels in Conjunctiva Up to 24 h Postadministration.
    Torrens I; Ganza Á; Hernández G; Gonzalo A; Zazpe A
    J Ocul Pharmacol Ther; 2022 Nov; 38(9):617-625. PubMed ID: 36269652
    [No Abstract]   [Full Text] [Related]  

  • 16. Ocular pharmacokinetics in rabbits using a novel dual probe microdialysis technique.
    Macha S; Mitra AK
    Exp Eye Res; 2001 Mar; 72(3):289-99. PubMed ID: 11180978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical Insights into the Retinal Dynamics of Vascular Endothelial Growth Factor in Patients Treated with Ranibizumab, Based on an Ocular Pharmacokinetic/Pharmacodynamic Model.
    Hutton-Smith LA; Gaffney EA; Byrne HM; Caruso A; Maini PK; Mazer NA
    Mol Pharm; 2018 Jul; 15(7):2770-2784. PubMed ID: 29734810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, Tissue Localization, Toxicity, and Treatment Efficacy in the First Small Animal (Rabbit) Model of Intra-Arterial Chemotherapy for Retinoblastoma.
    Daniels AB; Froehler MT; Pierce JM; Nunnally AH; Calcutt MW; Bridges TM; LaNeve DC; Williams PE; Boyd KL; Reyzer ML; Lindsley CW; Friedman DL; Richmond A
    Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):446-454. PubMed ID: 29368001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility study of chitosan as intravitreous tamponade material.
    Yang H; Wang R; Gu Q; Zhang X
    Graefes Arch Clin Exp Ophthalmol; 2008 Aug; 246(8):1097-105. PubMed ID: 18431591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Silico Ocular Pharmacokinetic Modeling: Delivery of Topical FK962 to Retina.
    Mori A; Yabuta C; Kishimoto Y; Kozai S; Ohtori A; Shearer TR; Azuma M
    J Ocul Pharmacol Ther; 2017 Sep; 33(7):556-566. PubMed ID: 28598703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.